Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease

Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease

Bibliographic Details
Main Authors:	Úna Bhreathnach, Laura Kearney, Stephen E. Langabeer
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137921000936

Similar Items

Association of HLA antigens and BCR-ABL transcripts in leukemia patients with the Philadelphia chromosome
by: Daiana Landenberger de Carvalho, et al.
Published: (2012-01-01)

Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation
by: Stephen E. Langabeer, et al.
Published: (2023-01-01)

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia.
by: Anahita Rafiei, et al.
Published: (2015-04-01)

Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 BCR-ABL1 Fusion Transcript
by: Julia W. Sheets, et al.
Published: (2020-12-01)

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Hend Abdelrasoul, et al.
Published: (2020-06-01)

The e1a3 BCR-ABL1 fusion transcript in Philadelphia chromosome-positive acute lymphoblastic leukaemia: a case report
by: Ziang Chen
Published: (2023-12-01)

Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias
by: Jing-Ying Zou, et al.
Published: (2023-12-01)

P190BCR-ABL1 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature
by: Samah Kohla, et al.
Published: (2021-07-01)

No Benefit of BCR-ABL1 Screening in Polycythemia
by: STEPHEN E. LANGABEER
Published: (2016-07-01)

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
by: Ibrahim O. Ahmed, et al.
Published: (2021-10-01)

A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review
by: Monica Piedimonte, et al.
Published: (2019-01-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

Clinical Utility of Droplet Digital PCR to Monitor BCR-ABL1 Transcripts of Patients With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Post-chimeric Antigen Receptor19/22 T-Cell Cocktail Therapy
by: Yuqi Guan, et al.
Published: (2021-04-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
by: Hong Hoe Koo
Published: (2011-03-01)

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)
by: Jeannig Berrou, et al.
Published: (2022-11-01)

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012)

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Marjanu Hikmah Elias, et al.
Published: (2012-11-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
by: Saskia Maletzke, et al.
Published: (2022-01-01)

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
by: Groffen John, et al.
Published: (2007-10-01)

Jak2/STAT6/c-Myc pathway is vital to the pathogenicity of Philadelphia-positive acute lymphoblastic leukemia caused by P190BCR-ABL
by: Run Qin, et al.
Published: (2023-01-01)

FISH mapping of Philadelphia negative <it>BCR/ABL1 </it>positive CML
by: Marin David, et al.
Published: (2008-07-01)

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults
by: Khalil Saleh, et al.
Published: (2022-04-01)

A rare case of Philadelphia-positive (P210BCR-ABL1) T-cell acute lymphoblastic leukemia/lymphoma associated with minimal residual disease persistence after intensive chemotherapeutic approaches
by: Shruti Shah, et al.
Published: (2024-01-01)

P100: BCR/ABL1 p230 transcript in B-lymphoblastic leukemia/lymphoma: A case report
by: Agshin Taghiyev, et al.
Published: (2024-01-01)

Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice
by: Vicki Xie, et al.
Published: (2018-02-01)

A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript
by: Aleksandra Mroczkowska, et al.
Published: (2022-02-01)

Current Concepts in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
by: Kathrin M. Bernt, et al.
Published: (2014-03-01)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
by: Panagiotis T. Diamantopoulos, et al.
Published: (2021-11-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: Yaghmaie M., et al.
Published: (2005-09-01)

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels
by: Funda Ceran, et al.
Published: (2022-08-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Atypical pulmonary presentation of Strongyloides stercoralis hyperinfection in a patient with philadelphia chromosome-positive acute lymphoblastic leukemia: Case report
by: Caitlyn J. Smith, et al.
Published: (2022-01-01)

Case report: BCR-ABL-positive acute lymphoblastic leukemia with bone destruction: a treatment dilemma
by: Shi Lijun, et al.
Published: (2024-02-01)

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
by: Hanna Kirchhoff, et al.
Published: (2022-02-01)

Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia
by: Rima Koka, et al.
Published: (2017-10-01)

Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity
by: Kathrin Rothfelder, et al.
Published: (2018-11-01)

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report
by: Shuang Fu, et al.
Published: (2023-06-01)